GeminIQ Website Logo

Viewing DNA free

Subscribe for full history, 90+ metrics, screener, watchlist...

Ginkgo Bioworks Holdings, Inc.

DNA

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
851441671112043125626167308409441,049
Marketable Securities Current
--255---0-----
Marketable Securities
218230-351270205------
Assets Current
Assets Current
3334104725065235656036627839031,0021,142
Accounts Receivable Net Current
132024212226222319241762
Accounts Receivable Net
000111110011
Inventory Net
-----------0
Prepaid Expense And Other Assets Current
171625222620192234384029
Property Plant And Equipment Net
157163168177186198204211211196188202
Operating Lease Right Of Use Asset
348354361368376383394406418221207342
Equity Securities Fv Ni And Without Readily Determ…
151515303332496262767985
Equity Method Investments
----------01
Intangible Assets Net Excluding Goodwill
4449576266697380917783100
Goodwill
------000484958
Other Assets Noncurrent
14047474747556060615897
Disposal Group Including Discontinued Operation As…
03----------
Assets
9901,0331,1201,1891,2311,2931,3771,4811,6251,5821,6652,026
Liabilities And Stockhold…
Accounts Payable Current
10161111111114162327911
Liabilities Current
Deferred Revenue Current
-----------43
Liabilities Current
73809611597116107114166169164168
Contract With Customer Liability Current
1315192528342823263444-
Accrued Liabilities And Other Liabilities
5048667957716576117108110115
Deferred Revenue Noncurrent
-----------170
Liabilities Noncurrent
Contract With Customer Liability Noncurrent
77787574758099105153166158-
Operating Lease Liability Noncurrent
404411417423429435439446452234222404
Other Liabilities Noncurrent
162223171815171821252419
Warrants And Rights Outstanding
----------612
Liabilities
570590611629618646661683792594568774
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Stockholders Equity
Additional Paid In Capital
6,6996,6756,6576,6276,6006,5776,5556,5286,5086,4456,3866,334
Stockholders Equity
4204435095606136477167988339871,0971,253
Retained Earnings Accumulated Deficit
-6,280-6,233-6,150-6,070-5,989-5,929-5,838-5,730-5,674-5,456-5,291-5,079
Accumulated Other Comprehensive Income Loss Net Of…
11222-1-20-2-21-3
Liabilities And Stockholders Equity
9901,0331,1201,1891,2311,2931,3771,4811,6251,5821,6652,026
Related Party
-000-001-1115-1
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
200200200200200200200200200200200200
Preferred Stock Shares Issued
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Revenues
-----------55

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-9.21%-0.68%-28.68%---------
20257.75%46.67%116.43%-5.87%-14.56%0.82%-17.88%-25.66%-11.33%-30.90%-17.30%-20.60%
2024-42.50%-63.70%-59.78%-41.52%-29.28%-28.67%38.97%37.54%59.24%-29.35%-23.71%-22.93%
2023---11.94%-9.95%-32.84%-4.03%13.42%-13.42%-29.61%-43.09%-46.97%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
4.57
5.15
4.92
4.39
5.41
4.88
5.62
5.79
4.71
5.34
6.11
6.78
Quick Ratio
4.33
4.95
4.66
4.20
5.14
4.70
5.44
5.59
4.51
5.12
5.87
6.60
Working Capital
259.80M
330.36M
375.87M
390.80M
426.31M
448.87M
495.48M
548.05M
617.21M
733.98M
837.89M
973.38M
Leverage & Debt
Debt to Equity
1.36
1.33
1.20
1.12
1.01
1.00
0.92
0.86
0.95
0.60
0.52
0.62
Interest Coverage TTM
-24.35
-19.82
-17.61
-8.86
-7.25
-10.21
-10.99
-10.44
-13.01
-11.72
-11.78
-20.89
Debt Ratio
0.58
0.57
0.55
0.53
0.50
0.50
0.48
0.46
0.49
0.38
0.34
0.38
Efficiency & Turnover
Asset Turnover TTM
0.12
0.13
0.14
0.12
0.15
0.16
0.15
0.17
0.13
0.10
0.12
0.12
Days Sales Outstanding TTM
48.46
55.58
49.21
51.13
35.36
40.53
31.36
53.32
61.17
93.96
71.17
132.99
Receivables Turnover TTM
7.53
6.57
7.42
7.14
10.32
9.01
11.64
6.85
5.97
3.88
5.13
2.74
Per Share Metrics
Diluted EPS TTM
-
-
-5.64
-6.10
-5.75
-8.70
-10.54
-12.46
-17.47
-17.03
-18.37
-17.52
Free Cash Flow Per Share TTM
-2.98
-3.08
-3.50
-2.57
-4.20
-6.37
-7.36
-7.41
-6.75
-6.43
-6.92
-8.31
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
82.78%
79.84%
81.48%
81.72%
85.22%
85.29%
83.02%
76.02%
76.41%
75.47%
81.50%
93.80%
Operating Profit Margin TTM
-231.13%
-201.90%
-185.29%
-207.91%
-141.71%
-203.55%
-246.54%
-217.21%
-334.93%
-396.11%
-343.76%
-380.68%
Net Profit Margin TTM
-219.60%
-201.05%
-183.81%
-212.15%
-149.91%
-207.66%
-240.94%
-223.00%
-347.40%
-409.12%
-355.08%
-354.70%
Growth Metrics
Net Revenue Growth (1Y)
-37.02%
-33.40%
-25.06%
-45.19%
-18.63%
8.93%
-9.71%
21.21%
2.58%
-46.49%
-47.36%
-54.36%
Net Income Growth (1Y)
-7.74%
-35.52%
-42.83%
-47.86%
-64.89%
-44.71%
-38.73%
-23.80%
-26.53%
-50.28%
-57.58%
-75.81%
EPS Growth (1Y)
-18.49%
-41.28%
-46.50%
-51.04%
-67.12%
-48.92%
-42.61%
-28.86%
-30.87%
-52.50%
-63.37%
-79.77%
Valuation Metrics
P/E TTM
-2.12
-1.20
-1.47
-2.39
-1.96
-0.65
-0.93
-0.65
-0.76
-2.72
-3.68
-4.13
P/B TTM
1.46
0.82
0.91
1.45
1.01
0.48
0.71
0.53
0.82
2.36
3.00
2.82
P/S TTM
4.65
2.41
2.71
5.07
2.94
1.36
2.24
1.46
2.66
11.14
13.07
14.66
Market Cap
615.36M
365.12M
460.85M
811.14M
617.16M
309.18M
509.61M
425.76M
686.30M
2.33B
3.29B
3.53B
Enterprise Value
443.34M
176.45M
248.48M
654.18M
365.81M
-46.23M
-51.97M
-190.45M
-44.06M
1.44B
2.34B
2.48B
Calculated Values
Free Cash Flow TTM
-185.32M
-183.37M
-193.89M
-143.21M
-230.20M
-345.30M
-382.13M
-387.26M
-346.60M
-322.24M
-336.30M
-405.20M
Net Debt
-172.02M
-188.67M
-212.37M
-156.96M
-251.35M
-355.41M
-561.57M
-616.21M
-730.37M
-887.21M
-944.07M
-1.05B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-05-22Sale
Owner: Coen, Steven P.
Title: See remarks
Shares: 307
Price/Share: $8.33
Value: $2,557.31
Shares Owned: 50,704
Relationship: Officer
Ownership: Direct
2026-04-17Sale
Owner: Coen, Steven P.
Title: See remarks
Shares: 324
Price/Share: $7.95
Value: $2,575.80
Shares Owned: 50,268
Relationship: Officer
Ownership: Direct
2026-04-13Sale
Owner: Coen, Steven P.
Title: See remarks
Shares: 33,171
Price/Share: $6.41
Value: $212,626.11
Shares Owned: 49,849
Relationship: Officer
Ownership: Direct
2026-04-10Sale
Owner: Shetty, Reshma P.
Title: See remarks
Shares: 124,727
Price/Share: $6.43
Value: $801,994.61
Shares Owned: 436,422
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2026-04-10Sale
Owner: Canton, Barry
Title: -
Shares: 124,727
Price/Share: $6.43
Value: $801,994.61
Shares Owned: 436,422
Relationship: TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
53.05%
Inst. Shares: 31,599,021
Shares Outstanding: 59,563,454
2025-12-31
58.04%
Inst. Shares: 32,189,859
Shares Outstanding: 55,457,676
2025-09-30
53.83%
Inst. Shares: 29,948,383
Shares Outstanding: 55,633,718
2025-06-30
59.88%
Inst. Shares: 32,850,300
Shares Outstanding: 54,858,982
2025-03-31
58.28%
Inst. Shares: 31,614,304
Shares Outstanding: 54,241,619

Ginkgo Bioworks Holdings, Inc. (DNA) — SEC Financial Statements & Analysis

Ginkgo Bioworks Holdings, Inc. (DNA) is a biological products, (no diagnostic substances) company, incorporated in DE. Ginkgo Bioworks Holdings, Inc. trades on NYSE, OTC as: DNA, DNABW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Ginkgo Bioworks Holdings, Inc. reported a -37.02% year-over-year revenue growth, a Gross Profit Margin of 82.78% (TTM), a Debt-to-Equity ratio of 1.36x, a Price-to-Sales (P/S) ratio of 4.65x (TTM), a Price-to-Book (P/B) ratio of 1.46x (TTM), at a market cap of $615.36M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-37.02%
Gross Profit Margin TTM
82.78%
Debt To Equity
1.36x
P/S TTM
4.65x
P/B TTM
1.46x
Market Cap
$615.36M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Ginkgo Bioworks Holdings, Inc. in?

Ginkgo Bioworks Holdings, Inc. (DNA) operates in the Biological Products, (No Diagnostic Substances) industry.

What is DNA's market cap?

Ginkgo Bioworks Holdings, Inc. (DNA) has a market capitalization of $615.36M as of 2026-06-30.

What exchange does DNA trade on?

Ginkgo Bioworks Holdings, Inc. (DNA) trades on the NYSE, OTC.

Where is Ginkgo Bioworks Holdings, Inc. incorporated?

Ginkgo Bioworks Holdings, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.